CD-10 Immunohistochemistry Test at Lahore PCR Lab

CD-10 Immunohistochemistry at Lahore PCR Lab

CD-10 Immunohistochemistry (IHC) is a specialized, highly sophisticated laboratory technique utilized in diagnostic pathology to detect the expression of the CD10 protein within tissue specimens. CD10, also known as Cluster of Differentiation 10, Common Acute Lymphoblastic Leukemia Antigen (CALLA), or neprilysin, is a 100-kDa cell-surface zinc-dependent metalloendopeptidase. This enzyme plays a pivotal role in inactivating various bioactive peptides. In clinical diagnostics, evaluating CD10 expression is crucial for subtyping hematologic malignancies, classifying solid tumors, and guiding targeted therapeutic strategies. At Lahore PCR Lab in Lahore, Pakistan, this advanced diagnostic test is performed using state-of-the-art automated staining platforms and interpreted by highly qualified consultant pathologists to ensure the highest level of diagnostic accuracy.

The immunohistochemical process works by exploiting the highly specific binding affinity between antigen and antibody. A tissue section, typically obtained via a biopsy or surgical resection, is mounted on a glass slide and exposed to primary monoclonal antibodies engineered specifically against the CD10 antigen. If the CD10 protein is present in the tissue, the antibodies bind to it. This binding is then visualized under a light microscope using a secondary detection system coupled with a chromogen (usually diaminobenzidine, or DAB), which produces a distinct brown precipitate at the site of antigen expression. Pathologists analyze the staining intensity, cellular localization (typically membranous or cytoplasmic), and the specific distribution pattern within the tissue architecture to formulate a definitive diagnosis.

The clinical value of CD10 IHC cannot be overstated. It serves as an indispensable tool in the differential diagnosis of various cancers. For instance, in hematopathology, it helps distinguish between different types of non-Hodgkin lymphomas, such as follicular lymphoma and mantle cell lymphoma. In surgical pathology, it assists in identifying renal cell carcinomas, differentiating endometrial stromal tumors from smooth muscle neoplasms, and evaluating specific cutaneous lesions. By providing precise molecular-level characterization of tumors, CD10 Immunohistochemistry at Lahore PCR Lab enables oncologists to design highly personalized treatment plans, predict clinical outcomes, and monitor disease progression effectively.

Clinical Procedure: What to Expect

Patient Preparation

Because CD10 Immunohistochemistry is performed on tissue samples that have already been extracted from the patient, there is no direct physical preparation required for the IHC staining process itself. However, the preparation phase is critical regarding specimen collection and submission:

• Specimen Submission: Patients or referring clinics must submit the Formalin-Fixed Paraffin-Embedded (FFPE) tissue block along with the corresponding hematoxylin and eosin (H&E) stained slides and the original histopathology report.
• Biopsy Preparation: If the biopsy has not yet been performed, patients must follow the specific preparation guidelines provided by their surgeon or radiologist (e.g., fasting for a core needle biopsy of abdominal organs or temporarily discontinuing blood-thinning medications).
• Fixation Guidelines: To preserve the antigenicity of the CD10 protein, the tissue must be fixed in 10% neutral buffered formalin as soon as possible after surgical removal, with an optimal fixation time of 6 to 72 hours.
• Clinical History: Providing a complete clinical history, including previous pathology reports, imaging results, and suspected diagnoses, is essential for accurate pathological correlation.

During the Procedure

The laboratory workflow for CD10 Immunohistochemistry at Lahore PCR Lab involves several highly controlled, automated steps to ensure reproducibility and prevent false-positive or false-negative results:

• Sectioning: Ultra-thin sections (approximately 3 to 4 microns thick) are cut from the paraffin block using a precision microtome and mounted on positively charged glass slides to prevent tissue detachment.
• Deparaffinization and Rehydration: The slides are heated and treated with xylene and graded alcohols to remove the paraffin wax and rehydrate the tissue cells.
• Antigen Retrieval: Heat-Induced Epitope Retrieval (HIER) is performed using a specialized buffer solution (typically EDTA or citrate buffer) at a controlled temperature to break the formalin-induced cross-links and expose the CD10 epitopes for antibody binding.
• Antibody Incubation: The tissue is incubated with a highly specific primary anti-CD10 monoclonal antibody under optimized temperature and time conditions.
• Detection and Visualization: A polymer-based secondary detection system conjugated with Horseradish Peroxidase (HRP) is applied, followed by the addition of DAB chromogen, which deposits a visible brown color at the site of CD10 expression.
• Counterstaining and Mounting: The slides are counterstained with hematoxylin to highlight cell nuclei in blue, dehydrated, cleared, and sealed with a coverslip for permanent storage and microscopic analysis.

When is a CD-10 Immunohistochemistry Performed?

Subtyping of Acute Lymphoblastic Leukemia (ALL)

CD10 was originally identified as the Common Acute Lymphoblastic Leukemia Antigen (CALLA). Pediatric and adult oncologists frequently request CD10 IHC (or flow cytometry) when evaluating bone marrow biopsies of patients suspected of having acute leukemia. CD10 is highly expressed in precursor B-cell acute lymphoblastic leukemia (B-ALL). Identifying its presence helps pathologists differentiate B-ALL from other forms of leukemia, such as acute myeloid leukemia (AML) or T-cell lymphoblastic leukemia, which is vital because the therapeutic protocols and prognostic outlooks for these diseases differ significantly.

Classification of Non-Hodgkin Lymphomas

In hematopathology, distinguishing between various small B-cell lymphomas is a common diagnostic challenge. CD10 is a normal marker for germinal center B-cells. Therefore, its expression is highly useful in identifying lymphomas of germinal center origin, such as follicular lymphoma and Burkitt lymphoma, which are typically CD10-positive. Conversely, other small B-cell neoplasms, such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and marginal zone lymphoma, are generally CD10-negative. CD10 IHC helps resolve these diagnostic dilemmas.

Diagnosis and Subtyping of Renal Cell Carcinoma (RCC)

Urologists and oncologists utilize CD10 IHC when evaluating renal masses or metastatic lesions of unknown primary origin. CD10 is strongly expressed in the brush border of normal proximal renal tubules and is highly preserved in clear cell renal cell carcinoma (ccRCC) and papillary renal cell carcinoma. When a patient presents with a metastatic tumor in the lungs, bone, or brain, a positive CD10 stain, in conjunction with other markers like PAX8 and RCC antigen, strongly points to a primary kidney origin, allowing for appropriate systemic therapy.

Identification of Endometrial Stromal Tumors

In gynecologic pathology, distinguishing endometrial stromal tumors from smooth muscle tumors of the uterus can be challenging due to overlapping histological features. Endometrial stromal nodules and low-grade endometrial stromal sarcomas (ESS) characteristically show diffuse and strong membranous and cytoplasmic positivity for CD10. In contrast, uterine leiomyomas and leiomyosarcomas are typically negative or show only focal, weak staining. CD10 IHC is therefore instrumental in confirming a diagnosis of endometrial stromal sarcoma.

Evaluation of Cutaneous and Adnexal Neoplasms

Dermatopathologists utilize CD10 IHC to differentiate various skin tumors. For example, CD10 is useful in distinguishing trichoblastomas (benign hair follicle tumors) from basal cell carcinomas (malignant epithelial tumors), as they exhibit different stromal and epithelial staining patterns. Additionally, CD10 is highly expressed in atypical fibroxanthoma (AFX), a rare skin cancer, helping differentiate it from other spindle cell lesions of the skin, such as spindle cell squamous cell carcinoma or melanoma, which are usually CD10-negative.

What Does a CD-10 Immunohistochemistry Detect?

CD10 Immunohistochemistry detects the presence, distribution, and intensity of the CD10 metalloendopeptidase enzyme within cellular membranes and cytoplasm. Specifically, it can detect and help characterize:

• Precursor B-cell acute lymphoblastic leukemia (B-ALL) cells showing strong membranous positivity.
• Follicular lymphoma cells exhibiting neoplastic germinal center differentiation.
• Burkitt lymphoma cells demonstrating diffuse, high-intensity CD10 expression.
• Clear cell renal cell carcinoma (ccRCC) cells showing membranous and luminal staining.
• Papillary renal cell carcinoma cells with positive cytoplasmic and membranous expression.
• Endometrial stromal sarcoma (ESS) cells showing diffuse, strong cytoplasmic and membranous positivity.
• Angioimmunoblastic T-cell lymphoma (AITL) cells, where CD10 is aberrantly expressed on neoplastic T-helper cells.
• Germinal center B-cell-like (GCB) subtype of diffuse large B-cell lymphoma (DLBCL).
• Normal germinal center B-cells within reactive lymph nodes (serving as an internal positive control).
• Normal proximal renal tubular epithelial cells showing strong apical brush border staining.
• Normal endometrial stromal cells during the proliferative phase of the menstrual cycle.
• Metaplastic breast carcinoma cells showing myoepithelial differentiation.
• Microglandular adenosis of the breast, helping distinguish it from tubular carcinoma.
• Hepatocellular carcinoma, which often displays a characteristic canalicular staining pattern.
• Atypical fibroxanthoma (AFX) showing diffuse cytoplasmic positivity.
• Stromal cells in bladder urothelial carcinoma, correlating with tumor invasion and grade.
• Pancreatic solid pseudopapillary neoplasms showing cytoplasmic and membranous positivity.
• Distinction of trichoblastoma (stromal positivity) from basal cell carcinoma (epithelial negativity).
• Absence of CD10 in chronic lymphocytic leukemia (CLL), confirming a non-germinal center origin.
• Absence of CD10 in mantle cell lymphoma, aiding in differential diagnosis.
• Absence of CD10 in marginal zone lymphoma, supporting diagnostic exclusion.
• Absence of CD10 in uterine leiomyosarcoma, helping rule out endometrial stromal sarcoma.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that waiting for pathology results can be an anxious time for patients and their families. The turnaround time for a CD-10 Immunohistochemistry test typically ranges from 3 to 5 working days. This timeframe is necessary to ensure meticulous tissue processing, precise sectioning, automated staining runs, and a comprehensive microscopic evaluation by our consultant pathologists. In complex cases requiring an extensive panel of multiple IHC markers to reach a definitive diagnosis, additional time may be required to ensure absolute clinical accuracy.

Once the pathology report is finalized and signed off by the reporting consultant, patients and referring physicians are notified immediately via SMS. Lahore PCR Lab offers convenient digital report access through our secure online portal. Patients can view, download, and print their high-resolution pathology reports from the comfort of their homes. Physical copies of the reports, complete with high-quality microscopic images if applicable, can also be collected directly from our main diagnostic center in Lahore.

CD-10 Findings Overview

The following table provides an overview of expected CD10 immunohistochemical staining patterns across various tissue types and clinical conditions:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Lymph Node Germinal Centers	Strong positive staining in normal germinal center B-cells; negative mantle zone.	Diffuse positivity in follicular lymphoma; loss of normal architecture.
Bone Marrow (Hematopoiesis)	Positive staining restricted to early B-cell precursors (hematogones).	Diffuse, intense positivity in precursor B-cell acute lymphoblastic leukemia (B-ALL).
Renal Tissue	Strong apical brush border staining in proximal convoluted tubules.	Diffuse membranous and cytoplasmic staining in clear cell renal cell carcinoma (ccRCC).
Endometrial Tissue	Strong positive staining in normal endometrial stroma (especially proliferative phase).	Diffuse, intense staining in endometrial stromal sarcoma (ESS).
Uterine Myometrium	Negative or only weak, focal staining in normal smooth muscle.	Strong diffuse staining in endometrial stromal tumors mimicking smooth muscle tumors.
Breast Tissue	Positive staining in normal myoepithelial cells surrounding ducts.	Loss of myoepithelial staining in invasive ductal carcinoma; positive in metaplastic carcinoma.
Skin Biopsy (Spindle Cell Lesions)	Negative in normal dermal fibroblasts.	Strong, diffuse cytoplasmic staining in atypical fibroxanthoma (AFX).
Liver Parenchyma	Distinct canalicular staining pattern in normal hepatocytes.	Altered or lost canalicular pattern in hepatocellular carcinoma (HCC).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for CD-10 Immunohistochemistry?

• Experienced Healthcare Professionals: Our pathology department is led by highly experienced consultant pathologists specializing in histopathology and immunohistochemistry.
• Patient-Focused Care: We prioritize patient comfort, clear communication, and timely assistance throughout the diagnostic process.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict international quality control standards, ensuring highly reproducible and reliable staining results.
• Professional Reporting: Our reports provide detailed diagnostic descriptions, staining intensity grades, and clinical correlations to assist oncologists.
• Modern Diagnostic Approach: We utilize advanced automated IHC staining platforms that minimize manual errors and optimize antibody binding.
• Comfortable Environment: Our sample collection centers in Lahore are designed to provide a clean, safe, and comfortable experience for all patients.
• Convenient Location: Strategically located in Lahore, our main laboratory and collection points are easily accessible from all parts of the city.
• Commitment to Accurate Diagnosis: We understand the critical nature of cancer diagnostics and are committed to delivering precise results that guide life-saving treatments.